Search research articles
Contact Us
Filters
Showing results (71-80 of 78) with videos related to
Page
of 8
Sort By:
You have reached the last page of results.
This site can display upto 78 results.
International Journal of Radiation Oncology, Biology, Physics
|
June 1, 2022
Stereotactic Radiation for the Comprehensive Treatment of Oligometastases (SABR-COMET): Extended Long-Term Outcomes
Stephen Harrow, David A Palma, Robert Olson, et al.
BMC Cancer
|
May 7, 2020
Stereotactic ablative radiotherapy for the comprehensive treatment of 1-3 Oligometastatic tumors (SABR-COMET-3): study protocol for a randomized phase III trial
Robert Olson, Lindsay Mathews, Mitchell Liu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 3, 2020
Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers: Long-Term Results of the SABR-COMET Phase II Randomized Trial
David A Palma, Robert Olson, Stephen Harrow, et al.
JAMA Oncology
|
March 7, 2024
Stereotactic Radiation Therapy in Early Non-Small Cell Lung Cancer and Interstitial Lung Disease: A Nonrandomized Clinical Trial
David A Palma, Houda Bahig, Andrew Hope, et al.
BMC Cancer
|
August 21, 2019
Stereotactic ablative radiotherapy for the comprehensive treatment of 4-10 oligometastatic tumors (SABR-COMET-10): study protocol for a randomized phase III trial
David A Palma, Robert Olson, Stephen Harrow, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 5, 2025
Dosimetric Outcomes of SBRT to Ultra-central Lung Tumors: Lessons from the SUNSET trial
Rohan Salunkhe, David A Palma, Andrew Warner, et al.
BMC Palliative Care
|
September 7, 2024
A randomized phase III trial of stereotactic ablative radiotherapy for patients with up to 10 oligometastases and a synchronous primary tumor (SABR-SYNC): study protocol
David A Palma, Meredith E Giuliani, Rohann J M Correa, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 21, 2024
Stereotactic Ablative Radiation for Oligoprogressive Cancers: Results of the Randomized Phase 2 STOP Trial
Devin Schellenberg, Zsolt Gabos, Adele Duimering, et al.
Page
of 8
Search research articles
Search
Showing results (71-80 of 78) with videos related to
Sort By:
Page
of 8
You have reached the last page of results.
This site can display upto 78 results.
International Journal of Radiation Oncology, Biology, Physics
|
June 1, 2022
Stereotactic Radiation for the Comprehensive Treatment of Oligometastases (SABR-COMET): Extended Long-Term Outcomes
Stephen Harrow, David A Palma, Robert Olson, et al.
BMC Cancer
|
May 7, 2020
Stereotactic ablative radiotherapy for the comprehensive treatment of 1-3 Oligometastatic tumors (SABR-COMET-3): study protocol for a randomized phase III trial
Robert Olson, Lindsay Mathews, Mitchell Liu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 3, 2020
Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers: Long-Term Results of the SABR-COMET Phase II Randomized Trial
David A Palma, Robert Olson, Stephen Harrow, et al.
JAMA Oncology
|
March 7, 2024
Stereotactic Radiation Therapy in Early Non-Small Cell Lung Cancer and Interstitial Lung Disease: A Nonrandomized Clinical Trial
David A Palma, Houda Bahig, Andrew Hope, et al.
BMC Cancer
|
August 21, 2019
Stereotactic ablative radiotherapy for the comprehensive treatment of 4-10 oligometastatic tumors (SABR-COMET-10): study protocol for a randomized phase III trial
David A Palma, Robert Olson, Stephen Harrow, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 5, 2025
Dosimetric Outcomes of SBRT to Ultra-central Lung Tumors: Lessons from the SUNSET trial
Rohan Salunkhe, David A Palma, Andrew Warner, et al.
BMC Palliative Care
|
September 7, 2024
A randomized phase III trial of stereotactic ablative radiotherapy for patients with up to 10 oligometastases and a synchronous primary tumor (SABR-SYNC): study protocol
David A Palma, Meredith E Giuliani, Rohann J M Correa, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 21, 2024
Stereotactic Ablative Radiation for Oligoprogressive Cancers: Results of the Randomized Phase 2 STOP Trial
Devin Schellenberg, Zsolt Gabos, Adele Duimering, et al.
Page
of 8